BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...Surface Oncology Inc. (NASDAQ:SURF) hired Wendy Dwyer as its first CBO. She was CBO at Portal Instruments Inc....
BioCentury | Dec 1, 2017
Company News

Takeda, Portal partner to develop needle-free biologics

...royalties. Portal Instruments Inc., Cambridge, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Drug delivery Jaime De Leon Entyvio MLN0002 vedolizumab Portal Instruments Inc. Takeda...
BioCentury | Jul 17, 2017
Company News

Management tracks

...and global brand leader of anti-infectives at Merck & Co. Inc. (NYSE:MRK). Biologics delivery company Portal Instruments Inc....
BioCentury | Jun 9, 2016
Strategy

Sunrise in Paris

...Small molecule therapies for genetic cardiomyopathies including hypertrophic cardiomyopathy and dilated cardiomyopathy. 2012 Not applicable Portal Instruments Inc....
BioCentury | Oct 26, 2015
Financial News

Portal Instruments completes venture financing

...2015-10-20 Type: Venture financing Raised: $10 million Investors: 5AM Ventures; Sanofi ; existing investors Note: Portal Instruments...
BioCentury | Oct 20, 2014
Financial News

Portal Instruments completes venture financing

Portal Instruments Inc. , Cambridge, Mass. Business: Drug delivery Date completed: 2014-10-15 Type: Venture financing Raised: $11 million Investors: Sanofi ; PBJ Capital; and an undisclosed investor WIR Staff...
Items per page:
1 - 6 of 6
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...Surface Oncology Inc. (NASDAQ:SURF) hired Wendy Dwyer as its first CBO. She was CBO at Portal Instruments Inc....
BioCentury | Dec 1, 2017
Company News

Takeda, Portal partner to develop needle-free biologics

...royalties. Portal Instruments Inc., Cambridge, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Drug delivery Jaime De Leon Entyvio MLN0002 vedolizumab Portal Instruments Inc. Takeda...
BioCentury | Jul 17, 2017
Company News

Management tracks

...and global brand leader of anti-infectives at Merck & Co. Inc. (NYSE:MRK). Biologics delivery company Portal Instruments Inc....
BioCentury | Jun 9, 2016
Strategy

Sunrise in Paris

...Small molecule therapies for genetic cardiomyopathies including hypertrophic cardiomyopathy and dilated cardiomyopathy. 2012 Not applicable Portal Instruments Inc....
BioCentury | Oct 26, 2015
Financial News

Portal Instruments completes venture financing

...2015-10-20 Type: Venture financing Raised: $10 million Investors: 5AM Ventures; Sanofi ; existing investors Note: Portal Instruments...
BioCentury | Oct 20, 2014
Financial News

Portal Instruments completes venture financing

Portal Instruments Inc. , Cambridge, Mass. Business: Drug delivery Date completed: 2014-10-15 Type: Venture financing Raised: $11 million Investors: Sanofi ; PBJ Capital; and an undisclosed investor WIR Staff...
Items per page:
1 - 6 of 6